Viewing Study NCT04037566


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2025-12-28 @ 2:25 AM
Study NCT ID: NCT04037566
Status: UNKNOWN
Last Update Posted: 2019-07-30
First Post: 2019-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma.
Sponsor: Xijing Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module